p70 S6 kinase (p70 s6k ) is a serine/threonine kinase which is activated through an unidenti®ed pathway by mitogenic stimuli. Here we demonstrate that stable-and transient-overexpression of wild type (WT)-p70 s6k results in perturbation of cytokinesis in NIH3T3 cells. Cells overexpressing s6k demonstrated a slow growth rate and lower viability, whereas cells overexpressing a mutant T229A-p70 s6k had a similar growth rate and viability as those of parental NIH3T3 cells. Moreover, s6k cells demonstrated several abnormalities in cellular morphology; both the cytoplasm and the nuclei were large and a proportion of the cells was multinucleated. Flow cytometric analysis of propidium iodidestained cells demonstrated that about 50% of the cells had 4N or greater content of DNA. When cell division in WT-p70 s6k cells was monitored by time-lapse video microscopy, cytokines was often incomplete after mitosis, producing binucleated cells. Addition of rapamycin to s6k cells, which inactivates endogenous and transfected p70 s6k , failed to reverse any of the morphological abnormalities. These indicate that overexpression of p70 s6k but not increases in activity of p70 s6k , is responsible for the phenotype. A molecule which interacts with p70 s6k may be involed in this regulation of cytokinesis.
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Introduction
Cell proliferation is regulated predominantly by protein phosphorylation cascades which are triggered by extracellular signals and controlled by a number of Ser/Thr or Tyr kinases/phosphatases in cells. p70 s6k is a Ser/Thr kinase which is ubiquitously activated at the G 0 /G 1 transition of the cell cycle by any mitogenic stimulus examined in mammalian cells (Susa et al., 1989; Reinhard et al., 1992; Proud, 1996) . It phosphorylates ®ve Ser residues at the C-terminus of ribosomal protein S6 in vitro (Bandi et al., 1993) and is the major kinase of S6 in vivo in mammalian cells (Ballou et al., 1991; Blenis et al., 1991) . The role of the p70 s6k activation pathway in cell proliferation is not fully understood; the pathway may regulate translation of mRNAs encoding ribosomal proteins which have a conserved sequence at their 5'-end (pyrimidine tract and following GC-rich regions) (Jeeries et al., 1994; Terada et al., 1994) . Thus, the p70 s6k pathway may be important for increases in protein synthesis which are required for quiescent cells to enter the cell division cycle (Terada et al., 1995) . p70 s6k also phosphorylates the cAMP-responsive activator CREM (de Groot et al., 1994) , suggesting that the kinase may have other roles in cell proliferation. A recent report demonstrated that p70 s6k is activated at the M/G 1 phases transition of the cell cycle as well as the G 0 /G 1 transition (Edelmann et al., 1996) Pearson et al., 1995) . The former group has a conserved sequence (Ser/Pro or Thr/Pro) seen in substrates of mitogen-activated protein kinase (MAPK) families or cyclin-dependent kinase (CDK) families (Banerjee et al., 1990) ; however, it is known that the p70 s6k activation/phosphorylation pathway is independent of extracellular signal-regulated kinase (ERK)/p90 rsk pathway (Ballou et al., 1991; Blenis et al., 1991) . Phosphorylation of the latter group is sensitive to rapamycin and wortmaninn , and it is believed that phosphatidylinositol 3-kinase (PI-3-kinase) and the structurally related enzyme, FRAP/RAFT, are involved in the regulation of phosphorylation/dephosphorylation of these sites (Brown et al., 1995; Weng et al., 1995a) . Recently, it was shown that Act/protein kinase B is involved in PI-3-kinase activation of p70 s6k (Burgering and Coer, 1995) , but direct regulators of p70 s6k are still not delineated. Phosphorylation of the latter set, especially  Thr  229 and Thr   389 , plays a critical role in activation of the kinase, since replacement of these Thr residues by Ala extinguishes kinase activity (Weng et al., 1995a; Pearson et al., 1995; Sugiyama et al., 1996) . Thr 229 of p70 s6k corresponds to conserved Thr/Ser residues in the VIII subdomain of the catalytic domain of Ser/Thr kinases, where phosphorylation is observed in activation of many other Ser/Thr kinases including protein kinase C (PKC), protein kinase A, CDK and MAPK (Sugiyama et al., 1996) . In addition, the N-terminal domain of p70 s6k is also pivotal for expression of sensitivity to rapamycin (Weng et al., 1995b; Cheatham et al., 1995; Mahalingam and Templeton, 1996) . More recently, Chou and Blenis reported that p70 s6k complexes with and is activated by the Rho family G proteins, Rac and Cdc42 (Chou and Blenis, 1996) . Thus, multiple pathways seem to regulate this unique serine/threonine kinase.
In the present study, we have characterized the phenotype of murine ®broblasts overexpressing wild type and mutant p70 s6k . Unexpectedly, overexpression of wild type p70 s6k predominantly interfered with cytokinesis, implying that a regulatory pathway of p70 s6k may play a role in a later phase of the cell cycle.
Results

Overexpression of WT-p70
s6k or T229A-p70 s6k in NIH3T3 cells
The cDNA encoding rat p70 s6k protein was inserted downstream of the nine amino acid (YPYDVPDYA) epitope of in¯uenza hemagglutinin (HA) in the CMV promoter vector (pXS). Thr 229 of p70 s6k were exchanged to Ala by PCR-assisted mutagenesis and both wild type (WT) and T229A p70 s6k are able to be distinguished from the endogenous p70 s6k by using anti-HA antibody (12CA5). The WT or T229A p70 s6k plasmid (pXSHA70 or pXSHA70T229A) was cotransfected with the neomycin-resistant gene (PLNCX) into NIH3T3 cells, and G418-resistant cells were selected. These cells were further screened by immunoblotting analysis using an anti-HA antibody. We established three clones expressing high levels of HA-tagged WT-p70 s6k and ten clones expressing high levels of HA-tagged T229A-p70 s6k . Figure 1 shows a representative result of the high expression of the proteins in these clones. Both a WT-p70 s6k expressing clone and a T229A-p70
s6k -expressing clone demonstrate multiple bands as apparent molecular weights of *70 kDa detected by the anti-HA antibody ( Figure  1a ). When cells were incubated for 1 h with rapamycin (10 ng/ml), a macrolide which speci®cally inactivates the p70 s6k pathway in cells Kuo et al., 1992; Price et al., 1992; Terada et al., 1992) , only a band with the fastest mobility was detected in both the WT-and T229A-clones. This band corresponds to the underphosphorylated species of p70 s6k (Terada et al., 1992) . In Figure 1b , parental NIH3T3 cells, WT-p70 s6k cells, or T229A-p70 s6k cells were labeled with 35 S-methionine for 3 h in the presence or absence of rapamycin and cell lysates were immunoprecipitated using polyclonal antibodies against the C-terminus of p70 s6k (anti-CT). In contrast to parental NIH3T3 cells which express barely detectable levels of the endogenous p70 s6k , both WT and the T229A clones expressed high levels of p70 s6k . Treatment with rapamycin also increased the mobility of these bands in both WT and T229A clones. By immunoblotting analysis using the anti-CT antibody, we determined that each of three WT clones or ten T229A clones expressed p70 s6k at approximately 30*100-fold higher levels than the endogenous p70 s6k (data not shown).
Kinase activity of WT-p70 s6k or T229A-p70 s6k in NIH3T3 cells
In order to examine the kinase activities of the transfected p70 s6k , the lysates from clones in proliferating status were immunoprecipitated with the anti-HA antibody, and the ability of the immunoprecipitants to phosphorylate S6 peptide in vitro was measured. As illustrated in Figure 1c , showed kinase activity which was inhibited completely in the presence of 10 ng/ml of rapamycin (Terada et al., 1994) . The concentration of the drug required to achieve 50% inhibition of the kinase activity (IC 50 ) was *0.5 ng/ml. In contrast, T229A-p70 s6k did not shown any capacity to phosphorylate S6 peptide in vitro, as previously reported in the other cell systems (Sugiyama et al., 1996) . Total p70 s6k activity was also measured by using anti-CT antibody (Figure 1d ). In contrast to the large increase in protein amount (Figure 1b) , the total activity of p70 s6k in vitro was only increased by 35% following overexpression of . These data indicate that most of the overexpressed WT-p70 s6k is not fully activated in these cells. Overexpression of T229A-p70 s6k reduced total p70 s6k activity by *60%. Taken together with the demonstration of more than 30-fold higher expression of T229A-p70 s6k compared to the endogenous kinase, the data indicate that T229A-p70 s6k does not serve as a dominant-negative mutant. Indeed, ribosomal protein S6 was phosphorylated in T229A-p70 s6k cells as well as in parental cells (data not shown). s6k overexpressing clone #13 (WT#13), or a T229A-p70 s6k overexpressing clone #9 (T229A#9) was treated with either rapamycin (10 ng/ml) or vehicle (0.1% ethanol) for 1 h. Cells (1610 6 ) were lysed in RIPA buer, and proteins were resolved in 7.5% SDS ± polyacrylamide gels and transferred to a nitrocellulose membrane. Transfected p70 s6k was speci®cally detected using anti-HA antibody (12CA5) as described in Materials and methods. . Cells were treated with either rapamycin (10 ng/ml) or vehicle (0.1% ethanol) for 1 h. Cells (1610 6 ) were lysed and p70 s6k was immunoprecipitated using either anti-HA antibody (c) or anti-CT antibody (d). The activity of immunoprecipitated p70 s6k was measured by [ 32 P]incorporation into S6 peptide as described in Materials and methods. Background activity was determined by the same procedure except no cellular lysates were added and that (about 80 kDa) of elongation factor two were detected only in the lysates of WT-p70 s6k cells (data not shown). This may re¯ect cells in the process of dying, since cleavage of various proteins during cell death has been reported (Casciola-Rosen et al., 1995) .
Abnormal morphology of WT-p70 s6k cells
Cell morphology was examined under light microscopy. T229A-p70 s6k cells (Figure 3b , c) demonstrated an identical phenotype as parental NIH3T3 cells (Figure 3a) . In contrast, s6k cells demonstrated a number of abnormalities (Figure 3d , e). The cytoplasm and the nucleus were often¯at and large compared to those of parental cells, and the cells tended to have many projections and sometimes vacuoles. Most dramatically, a proportion of WTp70 s6k cells were binucleated, occasionally with three or more nuclei (Figure 3d, e) . The percentage of cells with multiple nuclei increased in proportion to the number of passages of cells and about 10 ± 30% of the cells were multinucleated in WT-p70 s6k cells after 15 passages.
Rapamycin is known to inhibit p70 s6k activity through an unknown mechanism. Although addition of rapamycin (10 ng/ml) inhibited both the endogenous and transfected p70 s6k in the system (Figure 1 ), the drug did not restore the viability of WT-p70 s6k cells or alter the phenotype during the observation period of 1 week after addition of rapamycin (Figure 3f ). In addition, it further decreased the growth rate of cells (data not shown). These ®ndings suggested that the increased activity of p70 s6k is unlikely the cause for the abnormalities in cell division. Instead, the overexpression of the wild type protein itself likely is responsible for the phenotype.
Increase in DNA content of WT-p70 s6k cells
To investigate how these multinucleated cells are generated, we examined the DNA content of the cells. As illustrated in Figure 4 , parental NIH3T3 cells and T229A-p70 s6k cells demonstrated a normal distribution of DNA pattern for growing cells. In s6k overexpressing clones (#13, #14, #21), and three T229A-p70 s6k overexpressing clones (#3, #9, #11) were compared. All of the transfected cells were at 15 passages after establishment of the clones. Cells were plated at low density (about 10 4 cells in 10 cm culture plate) and average cell numbers in one microscopic vision area at the same magi®cation were counted daily. Averaged increases in relative cell numbers of multiple clones are illustrated in the ®gure. Cell viability was estimated by the ability of cells to exclude trypan blue dye as described in Materials and methods Overexpression of p70 s6k interferes with cytokinesis H Sugiyama et al contrast, cells (at 15 passages) showed increases in cells containing 4N or over 4N DNA. These data suggest that multinucleated cells were not due to decomposition of one 2N nucleus that is often seen in apoptotic cell death, but likely re¯ects either incomplete cell division or cell fusion.
Incomplete cytokinesis in WT-p70 s6k cells
The formation of multinucleated cells was then investigated by monitoring cell division using timelapse video microscopy. The mitosis phase of parental cells is shown in Figure 5 (parent). Cells did undergo normal anaphase (parent, 2*3) and telophase (parent, 4*6) of mitosis, and ®nally cytokinesis was completed producing two separated cells (parent, 9*10). T229A-p70 s6k cells showed the same cell division pattern as the parent cell (data not shown). In WT-p70 s6k cells, mitosis appeared to occur normally (WT#14, 1*3), producing two separated nuclei, and cytokinesis was initiated forming deep furrows (or contractile rings) (WT#14, 4*5). However, the duration for cytokinesis was longer compared to parental NIH3T3 cells; the mean duration from the division of nucleus (corre- sponding to #6 in parent cells in Figure 5 ) to the separation of cytoplasm (corresponding to #9 in parent cells in Figure 5 ), was 38+4 min in parental NIH3T3 cells and 111+28 min in WT-p70 s6k cells (15 passages). Moreover, cell division was not completed in approximately 20% of cells; instead, contractile rings became wider again (WT#14, 6*7), resulting in a cell containing two nuclei (WT#14, 8*10). These binucleated cells died within 24 ± 72 h and some of them entered into another mitotic phase with failure of cytokinesis, producing multinucleated cells.
Reproduction of abnormalities in NIH3T3 cells by transiently expressing WT-p70 s6k
If incomplete cytokinesis was indeed related to overexpression of , it was assumed that the same phenotype would be observed when s6k is transiently overexpressed. We transfected either the WT-p70 Figure 6 ). Since the expression levels of transfected protein were very high compared to endogenous p70 s6k , non-transfected cells are barely visible under these conditions. To visualize all of the cells, regardless of levels of expression of transfected protein, DNA was also stained with the Hoechst 33258 dye (right panel of each ®gure in Figure 6 ). As we predicted, similar abnormalities including macronuclear cells (Figure 6a ) and binucleated cells (Figure 6b ) were observed in a proportion of the cells transiently overexpressing WT-p70 s6k (5*15% of all the WTp70 s6k -overexpressed cells in 48 h after transfection). In contrast, cells overexpressing T229A-p70 s6k were normal (Figure 6c, d ).
An associated molecule with WT-p70 s6k
In an attempt to de®ne the mechanism whereby overexpressed wild type p70 s6k but not T229A-mutantp70 s6k interferes with cell division, associated proteins with these p70 s6k proteins were examined. Cells (WT#14 or T229A#9) were metabolically labeled with 35 S-methionine and lysed in a buer containing 0.1% Overexpression of p70 s6k interferes with cytokinesis H Sugiyama et al NP-40 with no other detergents. The lysates were immunoprecipitated using anti-CT, and the proteins recovered in the immune complexes were separated by SDS-6% polyacrylamide gel and visualized by fluorography. A protein with an apparent molecular weight of *220 kDa was recovered in lysates of WT-p70 s6k overexpressing clones, but not in those of T229A-p70 s6k overexpressing clones (Figure 7) . The association of this protein with WT-p70 s6k was not altered by addition of rapamycin (data not shown). The 220 kDa band did not react with the anti-p70 s6k antibodies or anti-HA antibody in immunoblotting, indicating that it is not derived from p70 s6k itself (e.s. an aggregated form of the kinase etc.) (data not shown).
Discussion
In this study, we demonstrate that stable-and transient-overexpression of WT-p70 s6k results in perturbation of cytokinesis in NIH3T3 cells. Cytochalasin B treatment is known to generate binucleated cells in ®broblasts (Krishan, 1972; Sanger and Holtzer, 1972) . Of interest, the cytochalasin B-treated cells could form deep cleavage furrows but failed to complete cytokinesis similar to cells overexpressing p70 s6k . Since cytochalasin B blocks both the association and dissociation of actin subunits, overexpression of p70 s6k may aect a similar pathway. In addition, a similar phenotype was reported when PKCq, but not PKCa, PKCbII or PKCz, was overexpressed in CHO cells (Watanabe et al., 1992) . Since p70 s6k has the highest homology with PKCs (42.5% homology in the catalytic domain of PKCq), there might exist a common mechanism underlying the two studies; although it was not clear where in the cell cycle the PKCqexpressing cells were targeted (Watanabe et al., 1992) . Further, Chou and Blenis recently reported that p70 s6k is directly regulated by the Rho family G proteins, Rac and Cdc42 (Chou and Blenis, 1996) . The Rho family controls not only the regulation of kinase cascades including Jun N-terminal kinase, p38 and p21-activated kinases, but various aspects of cytoskeletal organization (Zigmond, 1996) including actin and myosin organization (Kimura et al., 1996) . The overexpressed WT-p70 s6k may have disrupted the formation of the complex of Rho family proteins, thereby inhibiting cytokinesis. 4 cells/well in 6-well plates in D-MEM supplemented with 10% FCS. Sixteen hours after plating, the plates were viewed by a time-lapse video apparatus utilizing an inverted microscope connected to a video camera and a time-lapse video recorder. Proper temperature and carbon dioxide concentration were maintained in an incubator hood enclosing the microscope stage. Individual cell division was observed on a 456 cm 2 video monitor and photographs were taken from the monitor. Duration from 1 to 10 was 1.6 h and 7.4 h for parental cells (parent) and WT#14 cells, respectively A recent study demonstrated that p70 s6k is activated at the M/G 1 phase transition of the cell cycle (Edelmann, 1996) . Therefore, it is possible that p70 s6k itself plays a role in the cytokinesis phase of the cell cycle by phosphorylating cytoskeletal components. Up-or downregulation of the kinase in the M/G1 phase may be required for this transition. A constitutive increase in the kinase activity may be an obstacle to transit this phase. However, the increase in kinase activity by overexpression of WT-p70 s6k was minimum in contrast to the increases in protein levels (Figure 1d) . Moreover, inactivation of p70 s6k by rapamycin did not reverse the perturbation of cytokinesis (Figure 3 ). In addition, rapamycin did not block the G 2 /M to G 1 phase transition of T lymphocytes when cells were released from nocodazole-induced G 2 /M block (NT et al., unpublished observations). These data indicate that neither activation nor inactivation of p70 s6k is requisite for the M/G 1 transition but that overexpression of WTp70 s6k itself is responsible for the altered phenotype. Our data with rapamycin indicated that hyperphosphorylated (or activated) form of p70 s6k is not responsible for the cellular abnormalities observed in overexpressing cells. Since underphosphorylated species of p70 s6k preferentially complex with Rac1 or Cdc42 (Chou and Blenis, 1996) , it is possible that overexpression of the underphosphorylated form is important for development of the abnormal phenotype. Indeed, the kinase data (Figure 1c, d) suggested that most of the overexpressed WT-p70 s6k is maintained in an inactive form. However, amino acid exchange of Thr 229 to Ala, which often mimics underphosphorylated Thr, abrogated the eects on the cell cycle, despite a similar level of protein expression as the wild type kinase. This implies that a conversion of Thr 229 to Ala in p70 s6k may change the conformation of the kinase rather than simply mimicking the kinase with unphosphorylated Thr
229
. Alternatively, phosphorylation (and dephosphorylation) of Thr 229 may be important for the kinase to be modulated properly at the initial stages when the kinase is synthesized. By immunoprecipita- s6k and associated proteins were immunoprecipitated by anti-CT antibody and resolved in SDS-6% polyacrylamide gel. Radiolabeled proteins were visualized by¯uorography as described in Materials and methods. An arrow indicates a protein with an apparent molecular weight of 220 kDa tion, we detected a WT-p70 s6k -associated protein which was not found in complexes with T229A-p70 s6k ( Figure  7 ). Further identi®cation of this associated molecule, in addition to study of the involvement of Rho family proteins in these processes, will provide us with additional understanding of the p70 s6k pathway, especially as it pertains to the regulation of cytokinesis.
Recently, Mahalingam and Templeton (1996) demonstrated that Rat1 cells overexpressing p85 s6k had minimum changes in cell morphology. Instead, stable expression of a truncated form of p85 s6k with a 77-amino acid deletion at the N-terminus (DN77) resulted in abnormal morphology. p85 s6k is the longer isoform of p70 s6k which contain an additional 23 amino acids including a typical nuclear localization signal peptide (NLS) at the N-terminus . Although the study did not delineate any abnormality in the cell division cycle, the morphological changes seen in DN77-expressing Rat1 cells, such as elongated cells and numerous projections, were similar to what we observed in WT-p70 s6k overexpressing NIH3T3 cells (Figure 3 ). The discrepancies between these two independent studies may be due to: (1) that the level of overexpression of p70/85 s6k may be dierent in the two studies, or (2) the dierential nature of the p70 s6k isoform and the p85 s6k isoform. The latter idea is supported by the fact that DN77, which lacks the characteristic sequence of p85 s6k including NLS, induced similar morphological abnormalities as p70 s6k did in our study. Since the p85 s6k isoform localizes more exclusively to the nucleus , cytoplasmic localization of overexpressed S6 kinase may be required for interfering with cytokinesis.
Materials and methods
Plasmid constructs and mutagenesis
A full-length rat cDNA of p70 s6k was cloned into PXS vector (a CMV promoter vector). A DNA linker coding in¯uenza virus hemagglutinin (HA) epitope sequence (5'-ATGTATCCATACGACGTTCCAGATTACGCT-3') was introduced at the N-terminal end of the cDNA (PXSHA70). This HA-tagged PXSHA70 vector was used as a basic template vector for further construction of sitespeci®c mutants. Site-directed mutagenesis was performed using proof-reading PCR with the 16 : 1 combination of Taq and Pfu thermostable DNA polymerases. Full-length cDNA S6KEco was used as a PCR template (kindly provided by Dr G Thomas). A Thr-to-Ala mutation at amino acid position 229 (T229A) was generated by replacement of XmnI ± SwaI fragment containing Thr 229 with a ®lled-in EcoRI ± StuI PCR-fragment with Ala 229 . This Ala 229 -coding fragment was generated with two primers:
5' -GGGAATTCATGATGGAACAGTCACG-CATGCATTTTGTG -3' and 5'-GGAAAAGGCCTTA-GATATCATAGATTCATACGCAGGTGC -3'. Plasmid T229A clone bearing Ala 229 (GCA) mutation was con®rmed with SphI (GCATGC) and NsiI (ATGCAT).
Transfection and expression of the p70 S6 kinase in cells NIH3T3 cells were maintained in DMEM (GIBCO, Grand Island, NY) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (HyClone, Logan, UT). Ten mg of puri®ed plasmids were transfected with Lipofectamine (Life Technologies, Gaithersburg, MD) following a commercial protocol. To obtain stable expression clones of NIH3T3 cells, the linearized plasmids with ScaI were co-transfected with a 10-fold lower amount of neomycin-resistant vector (pLNCX). Neomycin-resistant clones were selected with 400 mg/ml of G418 over 2 to 3 weeks, and positive clones expressing HA-tagged wild type-or T229A-p70 s6k were further selected by immunoblotting analysis using an anti-HA monoclonal antibody raised against the YPYDVP-DYA peptide (12CA5, Boehringer Mannheim, Indianapolis, IN).
Metabolically labeling of cells and immunoprecipitation
Cells were pulse-labeled with 200 mCi/ml of 35 S-methionine (Dupont NEN, Boston, MA) for 3 ± 16 h in methionine-free DMEM supplemented with 10% dialyzed FCS (GIBCO). Cells were lysed at 48C with RIPA buer (25 mM Tris-HCl pH 7.4, 50 mM NaCl, 0.5% Na deoxycholate, 2% NP-40, 0.2% SDS, 1 mM PMSF, 50 mg/ml aprotinin, 50 mM leupeptin) or 0.1%-NP40 lysis buer (10 mM potassium phosphate, 1 mM EDTA, 5 mM EGTA, 10 mM MgCl 2 , 50 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 2 mM dithiothreitol, 40 mg/ml PMSF and 0.1% NP40). The lysates were incubated at 48C for 1 h with anti-HA antibody described above or rabbit polyclonal antibodies raised against the Cterminus of p70 s6k (anti-CT) (C-18, Upstate Biochemical Inc, Lake Placid, NY) . Immune complexes were absorbed to protein G-coupled sepharose beads (Pharmacia, Piscataway, NJ). Beads were then washed four times with the same lysis buer, suspended in sample loading buer and boiled for 5 min. Precipitated proteins were separated in an SDS 6*10% polyacrylamide gel. Gels were ®xed in methanol/acetate solution, treated with chemiampli®er solution and dried. Radiolabeled bands were visualized by auto¯uorography.
Immunoblot analysis
Cells were washed with PBS and lysed at 48C with RIPA buer. Lysates were resolved by either 7.5% polyacrylamide SDS-gels and transferred to nitrocellulose ®lters. After blocking of the ®lters with a solution containing 1% BSA, ®lters were incubated with anti-HA antibody. Speci®c reactive bands were detected using rabbit antimouse IgG conjugated to alkaline phosphatase. Development by the method employing the colorogenic substrates bromochlorindolyl phosphate and nitroblue tetrazolium.
In vitro kinase assay
Speci®c kinase activities of p70 s6k in the immune complex were determined by 32 P-incorporation into S6 peptide as described (Terada et al., 1993) . Cells (1610 6 ) were washed with PBS and lysed at 48C in 1 ml of lysis buer (10 mM potassium phosphate, 1 mM EDTA, 5 mM EGTA, 10 mM MgCl 2 , 50 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 2 mM dithiothreitol, 40 mg/ml PMSF and 0.1% NP40). For p70 s6k activity, the extract (500 ml) was incubated for 1 h at 48C with anti-HA antibody or anti-CT antibody. The immune complexes were absorbed to protein G-coupled sepharose beads (Pharmacia) for 1 h and washed twice with the lysis buer, and once with kinase buer (20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 mg/ml IP-20, 0.1 mg/ml BSA, 0.4 mM dithiothreitol). Following the ®nal wash, the immune complexes were suspended in 50 ml of the kinase buer containing 100 mM unlabeled ATP, 200 mCi/ml g-[ 32 P]ATP, 125 mM S6 peptide (RRRLSSLRA, Upstate Biotechnology). The reaction was allowed to proceed for 15 min at 308C and terminated by the addition of 20 ml of 250 mM EDTA followed by boiling for 5 min. After a brief centrifugation, the supernatant (25 ml) was applied to phosphocellulose paper and radioactivity was determined using a liquid scintillation counter.
Cell viability
Cell viability was estimated by the ability to exclude trypan blue dye. Cells were trypsinized, re-suspended in PBS, and mixed with trypan blue solution (®nal 0.2%, GIBCO). Numbers of stained and unstained cells were counted under the microscope. A total of at least 100 cells was counted per sample. The percentage of viable cells was calculated by dividing the number of cells excluding trypan blue by the total number of cells.
Immuno¯uorescence staining
Cells were plated and cultured on cover glass (0.1 mm thickness) in regular culture medium in CO 2 -incubator at 378C for 6 ± 16 h. Cells were ®xed with 3% paraformaldehyde, permealized with 0.2% Triton X-100, and incubated at room temperature in a blocking buer (DMEM and 10% FCS) for 30 min. Cells were then incubated for 1 h in blocking buer containing 0.05 mg/ml of anti-CT antibody. After washing the cells with PBS six times, cells were incubated for 1 h in blocking solution containing 0.05 mg/ ml of the secondary antibody (Cy3-conjugated Donkey anti-rabbit IgG, Jackson ImmunoResearch, West Grove, PA) and with 10 mg/ml of Hoechst 33258 dye (Calbiochem, La Jolla, CA). After washing six times with PBS, 100 ml of a mounting solution containing 2 mg/ml of O-phenylendiamine-diHCl (Sigma) and 90% glycerol was applied to the glass slide and covered. After sealing the cover glass with clear nail polish, the samples were examined under uorescence microscopy. Images of¯uorescence staining were taken using Ektachrome Elite 400 (Kodak, Rochester, NY).
Time-lapse video microscopy
Cell division was monitored using time-lapse video microscopy (Morelli et al., 1992) . Brie¯y, cells were plated at a concentration of 4610 4 cells/well in 6-well plates (Costar) in D-MEM supplemented with 10% FCS. Sixteen hours after plating, the plates were viewed by a time-lapse video apparatus utilizing an inverted microscope connected to a video camera (Nikon Inc. Instrument Division, Garden City, NY) and a time-lapse video recorder (Javelin, Anaheim, CA). Proper temperature and carbon dioxide concentrations were maintained by an incubator hood enclosing the microscope stage. A ®eld of eight to 15 cells was chosen at random and video frames were taken at a rate of 1 per 12 s. The plates were not removed during the course of the 48 h experiments. Individual cell movement and proliferation was observed on a 456 cm 2 video monitor and photographs were taken from the monitor.
Flow cytometric analysis of DNA content per cell DNA content per cell was measured by¯ow cytometry in propidium iodide stained cells. Cells (10 5 *10 6 ) in culture plates were collected using trypsin/EDTA, washed in PBS and suspended in 200 ml of saline. Cells in suspension were then ®xed by addition of 3 ml of 70% ethanol at 48C overnight, centrifugated and washed with PBS. The ®xed cells were incubated with 0.3 ml of 0.25 mg/ml ribonuclease (Sigma) in PBS at 378C for 15 min. The cell suspension was mixed with 0.3 ml of propidium iodide (Calbiochem) solution (50 mg/ml in PBS), and after 60 min analysed by¯ow cytometry (EPICS Pro®le, Coulter, Hialeah, FL) collecting red¯uorescence (4600 nm) with 488 nm excitation.
